Patent ID: 11932652
Assignee: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 0:
1. A compound represented by formula (I) and formula (II), a stereoisomer thereof or a pharmaceutically acceptable salt thereof,, wherein,
 is selected from a single bond and a double bond;
T is selected from N and C;
E is selected from 0, NR4 and CR5R6;
R1 is selected from C1-6 alkyl optionally substituted by 1, 2 or 3 Ra;
each of R2 is independently selected from H, F, Cl, Br, I, OH and NH2;
R3 is selected from C1-3 alkyl optionally substituted by 1, 2 or 3 Rb;
R4 is selected from H, and C1-6 alkyl optionally substituted by 1, 2 or 3 Rc;
each of R5 and R6 is independently selected from H, F, Cl, Br, I, OH, NH2, CN, COOH, and C1-3 alkyl optionally substituted by 1, 2 or 3 Rd;
ring A is selected from 5-6 membered heteroaryl;
ring B is selected from 4-6 membered heterocycloalkyl optionally substituted by 1, 2 or 3 Re;
m is selected from 1, 2 and 3;
each of Ra, Rb, Rc, Rd and Re is independently selected from F, Cl, Br, I, OH, NH2, CN, COOH, C1-3 alkyl and C1-3 alkoxy, wherein the C1-3 alkyl and C1-3 alkoxy are optionally substituted by 1, 2 or 3 R;
R is selected from F, Cl, Br, I, OH and NH2;
each of the 4-6 membered heterocycloalkyl and the 5-6 membered heteroaryl contains 1, 2, 3 or 4 heteroatoms or heteroatom groups independently selected from —NH—, —O—, —S— and N.